Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.255 USD | -1.18% | -6.34% | -16.33% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Immunic, Inc.
Upcoming events on Immunic, Inc.
Past events on Immunic, Inc.
2024-05-08 08:00 am | Q1 2024 Earnings Call |
2024-05-08 06:30 am | Q1 2024 Earnings Release |
2024-04-18 10:00 am | Noble Capital Markets Emerging Growth Virtual Health Care Equity Conference |
2024-04-14 | Accelerating Bio-Innovation UK Conference |
2024-04-09 01:30 pm | R&D Day |
2024-03-28 06:00 am | Society for Virology Meeting - Abstract Number: 73 |
2024-03-25 08:00 am | Society for Virology Meeting - Abstract Number: 107 |
2024-03-18 12:00 pm | Frontiers in Medicinal Chemistry Confererence - Poster Session II |
2024-03-17 01:00 pm | Frontiers in Medicinal Chemistry Confererence - Poster Session I |
2024-03-10 | Leerink Partners Global Biopharma Conference |
2024-03-05 | Clinical Trial Supply Europe Conference |
2024-03-05 | Temperature Controlled Logistics In Biopharmaceuticals Europe Conference |
2024-03-04 10:00 am | Extraordinary Shareholders Meeting |
2024-03-01 06:00 am | ACTRIMS Forum - Abstract Number: 6 |
2024-02-29 06:00 am | ACTRIMS Forum - Abstract Number: 509 |
2024-02-22 08:00 am | Q4 2023 Earnings Call |
2024-02-22 06:30 am | Q4 2023 Earnings Release |
2024-02-07 | BioCapital Europe Conference |
2024-01-31 | Genotoxicity and Nitrosamine Conference |
2024-01-07 | JPMorgan Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -37,0 -36,5 -1.39% | -49,0 -48,3 -1.35% | -75,4 -89,4 15.63% | -86,5 -81,9 -5.69% | -99,2 -98,8 -0.46% | -91,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -44,0 -46,3 4.97% | -92,9 -91,0 -2.11% | -120 -83,8 -43.75% | -93,6 -94,7 1.14% | -96,2 |
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -44,0 -46,3 4.97% | -92,9 -90,8 -2.36% | -120 -91,1 -32.18% | -93,6 -95,4 1.87% | -99,1 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | -2,81 -2,86 1.69% | -3,93 -3,89 -0.96% | -3,78 -2,90 -30.52% | -2,11 -2,14 1.52% | -1,00 |
Announcement Date | 16/03/20 | 26/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -21,4 -21,7 1.31% | -20,6 -22,3 7.61% | -20,1 -19,9 -1.29% | -24,4 -19,7 -23.66% | -27,3 -20,9 -30.57% | -25,0 -22,3 -12.37% | -23,6 -24,0 1.97% | -23,4 -22,9 -2% | -23,9 -22,2 -7.67% | -22,3 | -22,3 | -22,5 | -22,0 | -23,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,8 -20,4 -1.86% | -21,9 -22,4 2.24% | -21,2 -20,0 -6.36% | -56,5 -19,8 -184.85% | -25,3 -21,0 -20.15% | -24,0 -22,3 -7.73% | -22,8 -23,8 4.4% | -21,6 -22,6 4.76% | -29,6 -22,1 -33.96% | -22,2 | -22,2 | -22,4 | -22,0 | -23,0 |
Net income Million USD | Released Forecast Spread | -20,8 -20,8 0.15% | -21,9 -22,2 1.13% | -21,2 -20,1 -5.34% | -56,5 -27,7 -104.24% | -25,3 -21,6 -16.86% | -24,0 -23,1 -3.86% | -22,8 -24,3 6.25% | -21,6 -23,4 7.66% | -29,6 -22,4 -32.03% | -22,6 | -23,0 | -23,6 | -22,0 | -23,0 |
EPS USD | Released Forecast Spread | -0,74 -0,79 5.73% | -0,72 -0,72 -0.28% | -0,69 -0,66 -4.81% | -1,62 -0,74 -117.74% | -0,58 -0,52 -12.08% | -0,54 -0,53 -2.86% | -0,51 -0,55 6.85% | -0,48 -0,51 6.34% | -0,30 -0,26 -15.38% | -0,23 | -0,23 | -0,24 | -0,22 | -0,19 |
Announcement Date | 10/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 11/05/23 | 03/08/23 | 14/11/23 | 22/02/24 | 08/05/24 | - | - | - | - | - |
2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-07-23 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-25 01:00 am | ARGENX SE: Q2 2024 Earnings Release |
2024-07-29 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Immunic, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMUX Stock
- Calendar Immunic, Inc.